MLNT News and Press, Melinta Therapeutics Inc - Ordinary Shares From 07/02/19

Citing a "lack of clarity" regarding its ability to meet certain requirements under its loan with Vatera Investment Partners LLC, Melinta Therapeutics (NASDAQ: MLNT ) discloses that it will unable to draw additional funds under the $135M loan. More news on: Melinta Therapeutics, Inc., He...

WASHINGTON , July 1, 2019 /PRNewswire/ -- The Antimicrobials Working Group (AWG) announced today the addition of X-Biotix Therapeutics, Inc. (X-Biotix) to its coalition of companies with the mission to combat drug resistant infections and spur life-saving innovations. This new additi...

Melinta Therapeutics (MLNT) is a pharmaceutical company specialising in the development of treatments for bacterial infections. On Wednesday, June 19, we saw a huge spike in the stock price from $2 to over $6 at one point on news that the FDA had accepted a supplemental New Drug Application ((...

On June 19 th , 2019 Melinta Therapeutics ( MLNT ) announced the FDA accepted its BAXDELA sNDA for priority review. This sNDA would expand BAXDELA's label to include adult patients with community-acquired bacterial pneumonia (CABP). The FDA gave BAXDELA a 6-month review cycle and a PDUFA dat...

Gainers: Axovant Gene Therapies (NASDAQ: AXGT ) +40% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +24% . India Globalization Capital (NYSEMKT: IGC ) +17% . Pintec Technology (NASDAQ: PT ) +14% . ObsEva SA (NASDAQ: OBSV ) +12% . Overstock.com (NASDAQ: OSTK ) +12% . Fuwei Films (NASDAQ...

Melinta Therapeutics ( MLNT ) stock soared more than 200% on Wednesday, after it had announced that its supplemental New Drug Application (sNDA) was accepted by the FDA . The application seeks to expand the market opportunity for its drug BAXDELA. What also caused the stock to soar higher...

WASHINGTON , June 20, 2019 /PRNewswire/ -- The Antimicrobials Working Group (AWG), a coalition of companies with the mission to combat drug-resistant infections and spur life-saving innovations, today announced that eleven of its member companies will present data from their clinical...

Guardion Health Sciences (NASDAQ: GHSI ) +35%  on receiving a patent from the European Union for its proprietary medical device, the MapcatSF. More news on: Guardion Health Sciences, Inc., DiaMedica Therapeutics Inc., Melinta Therapeutics, Inc., Stocks on the move, Read more .....

MLNT stock more than tripled following Melinta Therapeutics Inc (NASDAQ:MLNT) announcing that its supplemental New Drug Application (sNDA) for Baxdela was approved by the FDA. Big Day for MLNT Stock Connecticut-based Melinta Therapeutics, which is involved in the development and marketi...

Gainers:  Melinta Therapeutics (NASDAQ: MLNT ) +180% . Arcturus Therapeutics (NASDAQ: ARCT ) +37% . Hebron Technology (NASDAQ: HEBT ) +26% . MYOS RENS Technology (NASDAQ: MYOS ) +22% . Armata Pharmaceuticals (NYSEMKT: ARMP ) +19% . AquaBounty Technologies (NASDAQ: AQB ) +19% . D...